子類別 會議論文/會議摘要 [2/2] 期刊論文 [22/23] 鄰近社群 于重元 [19/19] 劉柯俊 [85/98] 劉滄梧 [119/125] 劉界元(2003-2010) [3/3] 夏和雄(1996-2012) [26/31] 夏興國 [51/54] 姜乃榕 [82/94] 常慧如 [39/44] 張俊彥 [234/254] 張光裕 [69/79] 張憶壽 [103/106] 張文祥 [52/53] 張書銘 [89/91] 彭汪嘉康(1996-2007) [120/126] 施能耀 [37/43] 李家惠 [29/29] 李岳倫 [48/49] 林素芳 [32/32] 楊奕馨 [41/42] 江士昇 [88/90] 沈哲宏 [14/16] 洪文俊 [88/88] 莊雙恩 [82/91] 蔡坤志 [32/34] 蔡慧珍 [66/71] 蘇勇曄 [40/40] 郭靜娟 [71/76] 陳尚鴻 [45/48] 陳振陽 [72/72] 陳立宗 [443/510] 陳美霞(2002-2009) [1/1] 陳詩政 [2/2] 陳雅雯 [38/39] 黃智興 [55/55] 黃道揚 [26/26] 丁兆治(2000-2004) [5/5] 其他 [464/471] 劉敏(1996-2007) [60/62] 劉玫英(2004-2006) [2/2] 吳成文(1996-2008) [53/55] 曾思文(1997-2007) [4/4] 李冠德(1997-2004) [4/6] 林景太(1999-2007) [5/5] 楊文光(1996-1999) [21/21] 王全正(1996-2003) [4/4] 莊聲宏(1997-2004) [11/11] 詹宗晃(2000-2008) [2/2] 賴基銘(2004-2008) [41/47] 阮麗蓉(2000-2006) [6/7] 陳俊叡(2003-2007) [6/6] 馬彥英(1997-1999) [1/1] 黃奇英(2005-2007) [9/10] 社群統計 近3年內發表的文件:0(0.00%) 含全文筆數:24(96.00%) 文件下載次數統計 下載大於0次:24(100.00%) 下載大於100次:24(100.00%) 檔案下載總次數:13095(0.24%) 最後更新時間: 2024-11-28 13:36 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Deacetylation of HSPA5 by HDAC6 lea... E1A-mediated inhibition of HSPA5 su... The STAT3-miRNA-92-Wnt signaling pa... Targeting the VEGF-C/VEGFR3 axis su... A novel application of E1A in combi... Vascular endothelial growth factor-... Dicer elicits paclitaxel chemosensi... NF-kappaB-driven suppression of FOX... Functional mechanism of hypoxia-ind... Triple-layer dissection of the lung...

跳至: (選擇年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目1-10 / 25. (共3頁) 1 2 3 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2020-01	Deacetylation of HSPA5 by HDAC6 leads to GP78-mediated HSPA5 ubiquitination at K447 and suppresses metastasis of breast cancer [Erraturm: Oncogene. 2016 May;35(12):1517-1528.]	Oncogene. 2020 Jan;39(4):946-949.
2017-12	E1A-mediated inhibition of HSPA5 suppresses cell migration and invasion in triple-negative breast cancer [Erratum: Annals of Surgical Oncology. 2015;22(3):889-898.]	Annals of Surgical Oncology. 2017 Dec;24(Suppl. 3):685-686.
2017-04	The STAT3-miRNA-92-Wnt signaling pathway regulates spheroid formation and malignant progression in ovarian cancer	Cancer Research. 2017 Apr;77(8):1955-1967.
2017-01	Targeting the VEGF-C/VEGFR3 axis suppresses Slug-mediated cancer metastasis and stemness via inhibition of KRAS/YAP1 signaling	Oncotarget. 2017 Jan;8(3):5603-5618.
2016-11	Angiopoietin-like protein 1 antagonizes MET receptor activity to repress sorafenib resistance and cancer stemness in hepatocellular carcinoma	Hepatology. 2016Nov;64(5):1637-1651.
2016-09	A novel application of E1A in combination therapy with EGFR-TKI treatment in breast cancer	Oncotarget. 2016 Sep;7(39):63924-63936.
2016-07	Dicer elicits paclitaxel chemosensitization and suppresses cancer stemness in breast cancer by repressing AXL	Cancer Research. 2016 Jul;76(13):3916-3928.
2016-04-18	NF-kappaB-driven suppression of FOXO3a contributes to EGFR mutation-independent gefitinib resistance	Proceedings of the National Academy of Sciences of the United States of America. 2016 Apr 18;113(18):E2526-E2535.
2016-04	Vascular endothelial growth factor-C promotes EGFR-TKIs resistance and cancer stemness via SLUG of non-small cell lung cancer	Journal of Thoracic Oncology. 2016 Apr;11(4, Suppl.):S132-133.
2016-03	miR-520h is crucial for DAPK2 regulation and breast cancer progression	Oncogene. 2016 Mar 3;35(9):1134-1142.

顯示項目1-10 / 25. (共3頁) 1 2 3 > >> 每頁顯示[10|25|50]項目